Stocks · Korea
011040
KOSDAQ
KyungdongPharm
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER16.01x
PBR0.65x
EPS316 KRW
BPS7,812 KRW
ROE5.03%
Dividend yield5.93%
DPS300 KRW
Payout ratio94.94%
Returns and 52-week range
1W+0.60%
1M-0.78%
3M+1.61%
6M-7.66%
1Y-13.95%
YTD-11.85%
52W high6,270원
52W low4,700원
From 52W high-19.30%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 1,827억 | 83억 | 121억 | 4.5% |
| 2023 | 1,627억 | -250억 | -207억 | -15.3% |
| 2024 | 1,939억 | 26억 | 54억 | 1.4% |
| 2025 | 1,963억 | 77억 | 85억 | 3.9% |
| Quarterly | ||||
| 2024 4Q | 495억 | 22억 | 26억 | 4.5% |
| 2025 1Q | 458억 | 15억 | 16억 | 3.3% |
| 2025 2Q | 494억 | 5억 | -4억 | 1.0% |
| 2025 3Q | 489억 | 31억 | 44억 | 6.3% |
| 2025 4Q | 522억 | 26억 | 28억 | 4.9% |
| 2026 1Q | 478억 | 24억 | 47억 | 5.0% |
Company
Address: 경기도 화성시 양감면 제약단지로 224-3
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-05-14분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.